Back to User profile » Dr Eiji Shinozaki
Papers published by Dr Eiji Shinozaki:
Safety and efficacy of amrubicin monotherapy in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract: a single cancer center retrospective study
Kitagawa Y, Osumi H, Shinozaki E, Ota Y, Nakayama I, Suzuki T, Wakatsuki T, Ichimura T, Ogura M, Ooki A, Takahari D, Suenaga M, Chin K, Yamaguchi K
Cancer Management and Research 2019, 11:5757-5764
Published Date: 25 June 2019
Modified FOLFOX6 as a first-line treatment for patients with advanced gastric cancer with massive ascites or inadequate oral intake
Osumi H, Takahari D, Chin K, Ogura M, Ichimura T, Wakatsuki T, Suzuki T, Ota Y, Nakayama I, Ooki A, Suenaga M, Shinozaki E, Yamaguchi K
OncoTargets and Therapy 2018, 11:8301-8307
Published Date: 23 November 2018
Treatment features of systemic chemotherapy in young adults with unresectable advanced or recurrent gastric cancer
Nakayama I, Chin K, Takahari D, Ogura M, Ichimura T, Wakatsuki T, Osumi H, Ota Y, Suzuki T, Suenaga M, Shinozaki E, Yamaguchi K
Cancer Management and Research 2018, 10:5283-5290
Published Date: 1 November 2018
Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients
Sato Y, Matsusaka S, Suenaga M, Shinozaki E, Mizunuma N
OncoTargets and Therapy 2015, 8:3329-3336
Published Date: 11 November 2015
Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study
Suenaga M, Mizunuma N, Matsusaka S, Shinozaki E, Ozaka M, Ogura M, Yamaguchi T
Drug Design, Development and Therapy 2015, 9:3099-3108
Published Date: 16 June 2015
Perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01)
Suenaga M, Fujimoto Y, Matsusaka S, Shinozaki E, Akiyoshi T, Nagayama S, Fukunaga Y, Oya M, Ueno M, Mizunuma N, Yamaguchi T
OncoTargets and Therapy 2015, 8:1111-1118
Published Date: 18 May 2015
A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer
Suenaga M, Mizunuma N, Matsusaka S, Shinozaki E, Ozaka M, Ogura M, Chin K, Yamaguchi T
Drug Design, Development and Therapy 2015, 9:1653-1662
Published Date: 16 March 2015
Comparison between three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer
Ohhara Y, Suenaga M, Matsusaka S, Shinozaki E, Mizunuma N, Yamaguchi T
OncoTargets and Therapy 2015, 8:529-537
Published Date: 3 March 2015
Anticoagulant therapy for venous thromboembolism detected by Doppler ultrasound in patients with metastatic colorectal cancer receiving bevacizumab
Suenaga M, Mizunuma N, Shinozaki E, Matsusaka S, Ozaka M, Ogura M, Chin K, Yamaguchi T
OncoTargets and Therapy 2015, 8:243-249
Published Date: 27 January 2015